ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
ImmunoGen and Jazz collaborate to develop and market ADC products
pharmaceutical-technology
August 31, 2017ImmunoGen has entered a collaboration and option agreement to grant exclusive?worldwide rights to Jazz Pharmaceuticals for the development and commercialisation of two haematology-related antibody-drug conjugate (ADC) candidates, IMGN779 and IMGN632.
Pharma Sources Insight January 2025
